A detailed history of Prudential Financial Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 13,165 shares of HUMA stock, worth $16,982. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,165
Holding current value
$16,982
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

BUY
$1.15 - $2.77 $15,139 - $36,467
13,165 New
13,165 $27,000
Q2 2024

Aug 13, 2024

BUY
$2.87 - $9.1 $451,465 - $1.43 Million
157,305 New
157,305 $755,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $133M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.